Gamma glutamyltransferase and metabolic syndrome risk: a systematic review and dose-response meta-analysis
- PMID: 25363194
- DOI: 10.1111/ijcp.12507
Gamma glutamyltransferase and metabolic syndrome risk: a systematic review and dose-response meta-analysis
Abstract
Aims: We aimed to quantify and characterise in detail the nature of the dose-response relationship between baseline gamma glutamyltransferase (GGT) level and risk of incident metabolic syndrome (MetS) in the general population and determine the precise estimate of the magnitude of the association.
Methods: We performed a systematic review and dose-response meta-analysis of published prospective cohort studies. Relevant studies were identified in a literature search of MEDLINE, EMBASE and Web of Science up to May 2014. A potential nonlinear relationship between GGT levels and MetS was examined using restricted cubic splines. Study-specific estimates were combined using random-effects models.
Results: Of the 323 studies reviewed, we included 10 prospective cohort studies with data on 67,905 participants comprising of 6595 incident MetS cases. In pooled analysis of seven studies with relevant data, baseline GGT level was statistically significantly positively associated with risk of MetS in a nonlinear fashion (p for nonlinearity = 0.003). Comparing individuals in the top vs. bottom thirds of baseline GGT levels, relative risk for MetS in pooled analysis of all 10 eligible studies was 1.88 (95% confidence interval: 1.49-2.38). Evidence was lacking of publication bias among the contributing studies.
Conclusion: Baseline GGT level is positively and strongly associated with risk of the MetS in a nonlinear dose-response manner.
© 2014 John Wiley & Sons Ltd.
Similar articles
-
Gamma-glutamyltransferase and risk of hypertension: a systematic review and dose-response meta-analysis of prospective evidence.J Hypertens. 2015 Dec;33(12):2373-81. doi: 10.1097/HJH.0000000000000763. J Hypertens. 2015. PMID: 26485462 Review.
-
Gamma-glutamyl transferase and risk of type II diabetes: an updated systematic review and dose-response meta-analysis.Ann Epidemiol. 2014 Nov;24(11):809-16. doi: 10.1016/j.annepidem.2014.09.001. Epub 2014 Sep 8. Ann Epidemiol. 2014. PMID: 25263236 Review.
-
Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: systematic review and meta-analysis.Int J Cancer. 2015 Mar 1;136(5):1162-70. doi: 10.1002/ijc.29084. Epub 2014 Aug 1. Int J Cancer. 2015. PMID: 25043373 Review.
-
Alanine aminotransferase and risk of the metabolic syndrome: a linear dose-response relationship.PLoS One. 2014 Apr 29;9(4):e96068. doi: 10.1371/journal.pone.0096068. eCollection 2014. PLoS One. 2014. PMID: 24781277 Free PMC article.
-
Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies.Int J Clin Pract. 2012 Jul;66(7):692-8. doi: 10.1111/j.1742-1241.2012.02959.x. Int J Clin Pract. 2012. PMID: 22698421 Review.
Cited by
-
Gamma-glutamyl transpeptidase and indirect bilirubin may participate in systemic inflammation of patients with psoriatic arthritis.Adv Rheumatol. 2023 Oct 30;63(1):53. doi: 10.1186/s42358-023-00334-y. Adv Rheumatol. 2023. PMID: 37904193
-
Metabolic syndrome and transaminases: systematic review and meta-analysis.Diabetol Metab Syndr. 2023 Oct 30;15(1):220. doi: 10.1186/s13098-023-01200-z. Diabetol Metab Syndr. 2023. PMID: 37899468 Free PMC article. Review.
-
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.J Hepatol. 2023 Sep;79(3):592-604. doi: 10.1016/j.jhep.2023.04.025. Epub 2023 Apr 29. J Hepatol. 2023. PMID: 37121437 Review.
-
Significance of Fib4 index as an indicator of alcoholic hepatotoxicity in health examinations among Japanese male workers: a cross-sectional and retrospectively longitudinal study.Eur J Med Res. 2023 Jan 18;28(1):31. doi: 10.1186/s40001-022-00976-6. Eur J Med Res. 2023. PMID: 36650608 Free PMC article.
-
The potential effects of HECTD4 variants on fasting glucose and triglyceride levels in relation to prevalence of type 2 diabetes based on alcohol intake.Arch Toxicol. 2022 Sep;96(9):2487-2499. doi: 10.1007/s00204-022-03325-y. Epub 2022 Jun 17. Arch Toxicol. 2022. PMID: 35713687 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous